Shree Ganesh Bio-Tech (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Shree Ganesh Bio-Tech (India) Ltd. on BSE

Load latest

Shree Ganesh Bio-Tech (India) Ltd.

05 Sep 2022

0.91

-2.15%

Corp. Action

Shree Ganesh Biotech (India) Ltd - 539470 - Intimation Of Book Closure Pursuant To Regulation 42 …

BSE India

Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Wednesday, September 21, 2022 to Tuesday, September 27, 2022 (both days inclusive) for taking record of the Members of the Company for the purpose of Annual General Meeting of the Company to be held on September 27, 2022. You are requested to take note of the above and bring this to the notice of all concerned. Thanking you,

pdf

Shree Ganesh Bio-Tech (India) Ltd.

05 Sep 2022

0.91

-2.15%

AGM

Shree Ganesh Biotech (India) Ltd - 539470 - Submission Of Notice Of Annual General Meeting Under …

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Notice of 12th Annual General Meeting of the company to be held on 27.09.2022 This is for your information and records. Thanking you,

pdf

Shree Ganesh Bio-Tech (India) Ltd.

12 Aug 2022

0.91

-2.15%

Result

Shree Ganesh Biotech (India) Ltd - 539470 - Update In Limited Review Report For The Results …

BSE India

From your email it comes to our notice that there was typo error from auditor and written "consolidated" instead of "standalone" in Limited Review Report earlier filed for financial results dated 25.07.2022.Henceforth, we are rectifying the same. Kindly considered same in your records. Thanking You.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

01 Aug 2022

0.91

-2.15%

SAST

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shreeji Capital Partners

pdf

Shree Ganesh Bio-Tech (India) Ltd.

01 Aug 2022

0.91

-2.15%

SAST

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, …

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shreeji Capital Partners

pdf

Shree Ganesh Bio-Tech (India) Ltd.

25 Jul 2022

0.91

-2.15%

Result

Shree Ganesh Biotech (India) Ltd - 539470 - Revised Un-Audited Financial Result Quarter Ending 30Th June, …

BSE India

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Monday July 25, 2022 at the Registered Office of the Company and transacted the following business. Note: Due to typo error and erratum find herewith revised Un-Audited Financial Result quarter ending 30th June, 2022 pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015. Thanking You,

pdf

Shree Ganesh Bio-Tech (India) Ltd.

25 Jul 2022

0.91

-2.15%

Result

Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Outcome for Revised Un-Audited Financial Result …

BSE India

pdf

Shree Ganesh Bio-Tech (India) Ltd.

25 Jul 2022

0.91

-2.15%

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation …

BSE India

Pursuant to SEBI Circular - CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding statement on Deviation or variation for proceeds of public issue/Rights Issue/preferential issue, Qualified institutional placement (QIP) etc., read with Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform that: The Company does not have any funds remaining unutilised as on 30th June 2022, or as on date, out of the proceeds of public issue/Rights Issue/preferential issue, qualified institutional placement (QIP) etc., if any undertaken by it at anytime in the past. In view of the aforesaid, no information is being provided by way of Annexure-A pursuant to the said Regulation / Circular. This is for your information and records. Thanking You.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

25 Jul 2022

0.91

-2.15%

Result

Shree Ganesh Biotech (India) Ltd - 539470 - Un-Audited Financial Result Quarter Ending 30Th June, 2022 …

BSE India

1. Considered and approved Un-audited financial results for the quarter ended as on 30th June, 2022. 2. Consider and accepted the Resignation of Mr.Varun Aghara from the Post of Chief Financial Officer of the Company w.e.f 25.07.2022. 3. Mr. Kishan Nityanand Naidu is appointed as Chief Financial Officer of the Company w.e.f 25.07.2022. 4. Ms.Manisha Patel has resigned from the post of directorship of the Company w.e.f 25.07.2022. 5. Mr.Nimesh Parmar is appointed as Director of the Company w.e.f 25.07.2022. 6. Ms. Amruta Solanki is appointed as Director of the Company w.e.f 25.07.2022. Kindly take the same on your record and oblige. Thanking You,

pdf